| Drug Name | Olmepress(Olmesartan) |
|---|---|
| Drug Class |
Anti-hypertension
|
| Risk minimization type |
Direct Healthcare Professional Communication DHPC
|
| Specialty (Theraputic area) |
Cardiology
|
| Risk |
Restriction of combined use of medicines affecting the renin-angiotensin aldosterone system (RAAS) for medicinal products containing Olmepress (Olmesartan) |
| other |
|